Share on Pinterest Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight in ... 37.1 kilograms per square meter (kg/m 2).

Mounjaro is the brand name for Tirzepatide, a drug used to treat Type 2 diabetes. In 2023, the United States Food and Drug Administration (FDA) approved it for weight loss. The caption ended as ...

Golden Globes host Nikki Glaser shared why she supports people using the injectable drug Ozempic for weight loss, and also ...

Kennedy Jr. wrote in a caption alongside photos of himself hiking in California ... In other news: Pennsylvania officials say weight loss drugs might lead to more than $1 billion in new Medicaid costs ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.